secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rallybio Corp (RLYB)
CIK:        0001739410
Form:       8-K
Filed at:   2026-10-26T20:53:10+00:00
Accession:  0001193125-26-432114
Event type: dividend
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Rallybio declares $13.56/share special cash distribution (~$82.7M) tied to Avenzo merger
--------------------------------------------------------------------------------

- Special cash distribution estimated at $82.7M aggregate, or $13.56 per share, based on 6,378,168 shares and equivalents outstanding as of October 21, 2026.
- Record date November 5, 2026; funds deposited with transfer agent that day and scheduled for distribution November 13, 2026; Nasdaq ex-dividend date November 6, 2026.
- Due bill period expected November 4-6, 2026: buyers in that window receive the distribution; holders must hold through November 6, 2026 to be entitled.
- Payment conditioned on the required stockholder vote at the annual meeting set for 10:00 a.m. ET on November 4, 2026; merger closing expected on or about November 6, 2026.
- Board also fixed the November 5, 2026 record date for the previously announced contingent value rights distribution; actual cash amount may be higher or lower than the $82.7M estimate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739410/000119312526432114/0001193125-26-432114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739410/000119312526432114/d353286d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-432114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer